What company owns Doximity?
Doximity
| Type | Public |
|---|---|
| Founded | June 2010 |
| Headquarters | San Francisco, California |
| Key people | Jeff Tangney, CEO (co-founder of Epocrates) |
| Revenue | US$206.897 Million (Fiscal Year Ended 31 March 2021) |
What is Doximity business model?
Doximity makes money by charging subscription fees for its marketing, hiring, as well as telehealth solutions. Consequently, Doximity operates on a subscription-based business model. Founded in 2010, Doximity has become the leading medical social network in the United States.
What was Doximity IPO price?
$26
The company had a celebrated IPO last June, and its stock soared on its first day of trading from an IPO price of $26 to close 115% higher at $56.
Did Doximity go public?
Doximity has released two earnings results since going public. The first one was for the first quarter of fiscal 2022 (period ending June 30, 2021), where it reported sales of $72.7 million which doubled the prior-year period’s total.
Is Doximity a profitable company?
Doximity, a health tech company that claims to have more than 80% of doctors on its network, brought in $79 million in revenue in the second quarter, a 76% jump from the same period a year ago. The company’s second-quarter 2020 revenue came to $45 million.
Who is CEO of Doximity?
Jeff Tangney (Jul 2010–)Doximity / CEO
What is the cost of Doximity?
While using Doximity is free, its software licensing, customization and maintenance costs can run up to $12,000 per user, per year for the basic software licensing package. Just the EMR — Electronic Medical Records — subscription costs around $500 per month.
Can companies advertise on Doximity?
Doximity supports sponsored ads with robust segmenting controls that can target audiences geographically, socioeconomically, and through a doctor’s clinical interests, trial work, and coauthored article subject matter.
Should I sell Doximity?
There are currently 1 sell rating, 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Doximity stock.
How much did Doximity raise in IPO?
$606 million
The company sold 23.3 million shares for $26, above its initial share price between $20 and $23 per share, and raised nearly $606 million in its initial public offering (IPO). Doximity opened at $50 per share Friday morning.
Is Doximity profitable?
Doximity brought in revenue of $116 million in 2019 and revenue grew 78% to reach $207 million in 2020. The company is profitable, bringing in $30 million and $50 million in net income in 2019 and 2020, respectively.
Is Doximity a buy?
Doximity has received a consensus rating of Buy.
What does the Doximity IPO mean for the healthcare industry?
The IPO marks Doximity’s first financing since 2014, when the company raised $54 million at a $355 million valuation, according to PitchBook. As part of the offering, Doximity reserved 15% of the shares for doctors in the network.
What is Doximity stock price at $53?
The stock, trading under ticker symbol “DOCS,” closed at $53, giving the company a market cap of $9.4 billion. Founded in 2010, Doximity has grown rapidly in recent years by becoming the primary app that doctors use to stay connected with one another, sharing the latest research and updates on new drugs.
How did Doximity’s revenue jump 77%?
Revenue jumped 77% in the latest fiscal year to $206.9 million, according to the company’s prospectus. Because Doximity spends virtually no money on advertising, operating costs are lower than at most venture-backed software companies. That allowed Doximity to boost net income 69% to $50.2 million in the fiscal year that ended in March.
How does Doximity make money?
Founded in 2011, Doximity has established itself as the LinkedIn for doctors and now has over 1.8 million medical professionals on its network. The company makes money primarily by allowing drugmakers to promote products and services to doctors and as a recruiting tool for medical systems.